BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruggiero RN, Rossignoli MT, De Ross JB, Hallak JEC, Leite JP, Bueno-Junior LS. Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research. Front Pharmacol 2017;8:399. [PMID: 28680405 DOI: 10.3389/fphar.2017.00399] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Hazani R, Lavidor M, Weller A. Treatments for Social Interaction Impairment in Animal Models of Schizophrenia: A Critical Review and Meta-analysis. Schizophr Bull 2022:sbac093. [PMID: 35925025 DOI: 10.1093/schbul/sbac093] [Reference Citation Analysis]
2 Morris G, Sominsky L, Walder KR, Berk M, Marx W, Carvalho AF, Bortolasci CC, Maes M, Puri BK. Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia. Mol Neurobiol 2022. [PMID: 35347586 DOI: 10.1007/s12035-022-02800-y] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Ruggiero RN, Rossignoli MT, Marques DB, de Sousa BM, Romcy-Pereira RN, Lopes-Aguiar C, Leite JP. Neuromodulation of Hippocampal-Prefrontal Cortical Synaptic Plasticity and Functional Connectivity: Implications for Neuropsychiatric Disorders. Front Cell Neurosci 2021;15:732360. [PMID: 34707481 DOI: 10.3389/fncel.2021.732360] [Reference Citation Analysis]
4 Helcman M, Šmejkal K. Biological activity of Cannabis compounds: a modern approach to the therapy of multiple diseases. Phytochem Rev. [DOI: 10.1007/s11101-021-09777-x] [Reference Citation Analysis]
5 Onofrychuk TJ, Cai S, McElroy DL, Roebuck AJ, Greba Q, Garai S, Thakur GA, Laprairie RB, Howland JG. Effects of the cannabinoid receptor 1 positive allosteric modulator GAT211 and acute MK-801 on visual attention and impulsivity in rats assessed using the five-choice serial reaction time task. Prog Neuropsychopharmacol Biol Psychiatry 2021;109:110235. [PMID: 33373679 DOI: 10.1016/j.pnpbp.2020.110235] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Kwan Cheung KA, Mitchell MD, Heussler HS. Cannabidiol and Neurodevelopmental Disorders in Children. Front Psychiatry 2021;12:643442. [PMID: 34093265 DOI: 10.3389/fpsyt.2021.643442] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Jenkins BW, Khokhar JY. Cannabis Use and Mental Illness: Understanding Circuit Dysfunction Through Preclinical Models. Front Psychiatry 2021;12:597725. [PMID: 33613338 DOI: 10.3389/fpsyt.2021.597725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Jorratt P, Hoschl C, Ovsepian SV. Endogenous antagonists of N-methyl-d-aspartate receptor in schizophrenia. Alzheimers Dement 2021;17:888-905. [PMID: 33336545 DOI: 10.1002/alz.12244] [Reference Citation Analysis]
9 Escelsior A, Sterlini B, Murri MB, Serafini G, Aguglia A, da Silva BP, Corradi A, Valente P, Amore M. Red-hot chili receptors: A systematic review of TRPV1 antagonism in animal models of psychiatric disorders and addiction. Behavioural Brain Research 2020;393:112734. [DOI: 10.1016/j.bbr.2020.112734] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Radaic A, Martins-de-souza D. The state of the art of nanopsychiatry for schizophrenia diagnostics and treatment. Nanomedicine: Nanotechnology, Biology and Medicine 2020;28:102222. [DOI: 10.1016/j.nano.2020.102222] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Lavender E, Hirasawa-Fujita M, Domino EF. Ketamine's dose related multiple mechanisms of actions: Dissociative anesthetic to rapid antidepressant. Behav Brain Res 2020;390:112631. [PMID: 32437885 DOI: 10.1016/j.bbr.2020.112631] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
12 Tang SW, Tang WH. Hallucinations: diagnosis, neurobiology and clinical management. Int Clin Psychopharmacol 2020;35:293-9. [PMID: 32324611 DOI: 10.1097/YIC.0000000000000313] [Reference Citation Analysis]
13 Kozela E, Krawczyk M, Kos T, Juknat A, Vogel Z, Popik P. Cannabidiol Improves Cognitive Impairment and Reverses Cortical Transcriptional Changes Induced by Ketamine, in Schizophrenia-Like Model in Rats. Mol Neurobiol 2020;57:1733-47. [PMID: 31823199 DOI: 10.1007/s12035-019-01831-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
14 Almeida V, Levin R, Peres FF, Suiama MA, Vendramini AM, Santos CM, Silva ND, Zuardi AW, Hallak JEC, Crippa JA, Abílio VC. Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit. Neuropharmacology 2019;155:44-53. [DOI: 10.1016/j.neuropharm.2019.05.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
15 Storozhuk MV, Moroz OF, Zholos AV. Multifunctional TRPV1 Ion Channels in Physiology and Pathology with Focus on the Brain, Vasculature, and Some Visceral Systems. Biomed Res Int 2019;2019:5806321. [PMID: 31263706 DOI: 10.1155/2019/5806321] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
16 Kossakowski R, Schlicker E, Toczek M, Weresa J, Malinowska B. Cannabidiol Affects the Bezold-Jarisch Reflex via TRPV1 and 5-HT3 Receptors and Has Peripheral Sympathomimetic Effects in Spontaneously Hypertensive and Normotensive Rats. Front Pharmacol 2019;10:500. [PMID: 31178718 DOI: 10.3389/fphar.2019.00500] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
17 Stark T, Ruda-kucerova J, Iannotti FA, D'addario C, Di Marco R, Pekarik V, Drazanova E, Piscitelli F, Bari M, Babinska Z, Giurdanella G, Di Bartolomeo M, Salomone S, Sulcova A, Maccarrone M, Wotjak CT, Starcuk Z, Drago F, Mechoulam R, Di Marzo V, Micale V. Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia. Neuropharmacology 2019;146:212-21. [DOI: 10.1016/j.neuropharm.2018.11.035] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
18 Bueno-Junior LS, Leite JP. Input Convergence, Synaptic Plasticity and Functional Coupling Across Hippocampal-Prefrontal-Thalamic Circuits. Front Neural Circuits 2018;12:40. [PMID: 29875637 DOI: 10.3389/fncir.2018.00040] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]